They demonstrated that the levels of infiltrating Th17 cells and ascites IL-17 are reduced in advanced cancer cases, and that IL-1β stimulates Th17 cells for IL-17 production and recruitment of cytotoxic T cells [132]. The gene discussed is IL1B; the disease is cancer.